Tacrosan

TACROSAN

Tacrolimus

Novartis Pharmaceuticals (Pvt) Ltd.

Drug Identity

Active Ingredient
Tacrolimus
Drug Class
Immunosuppressants
ATC Code
D11AH01, L04AD02
Status
Essential Medicine

How to Take It

Dosage information not available for this product.

Safety Alerts

Avoid concurrent administration with ciclosporin (care if patient has previously received ciclosporin)

Important Warnings

Increased risk of infections, lymphoproliferative disorders, malignancies, neurotoxicity, QT-interval prolongation, UV light (avoid excessive exposure to sunlight and sunlamps)
Cardiomyopathy has been reported in children given tacrolimus after transplantation
Patients should be monitored carefully by echocardiography for hypertrophic changes
dose reduction or discontinuation should be considered if these occur
Monitor visual status, blood glucose, haematological and neurological parameters and whole blood 'trough' concentrations of tacrolimus (especially during episodes of diarrhoea), may affect performance of skilled tasks (e

Side Effects

Alopeciaanaemiaanorexiaanxietyarthralgiaascitesbile-duct abnormalitiesblood disorderscholestasisconvulsionconfusiondepressiondizzinessdyspneaelectrolyte disturbances

Price Intelligence

Rs 6,710
Servaid observed price · as of 30 July 2026
No approved ceiling matched to this exact pack and strength.
Prices across sources
ServaidRs 6,710

Should you consider an alternative?

Other options containing Tacrolimus, and what they are not.You pay Rs 5,864 more than the cheapest equivalent

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.